Brisbois, T D <br/><br/>
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2011 
 - 2086-2093 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdq727  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Double-Blind Method<br/>Dronabinol--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Neoplasms--drug therapy<br/>Olfactory Perception--drug effects<br/>Palliative Care--methods<br/>Pilot Projects<br/>Placebos<br/>Quality of Life<br/>Taste Perception--drug effects